Modulating cell differentiation and treating myeloproliferative disorders with JNK/MKK inhibitors

Details for Australian Patent Application No. 2003231950 (hide)

Owner CELGENE CORPORATION

Inventors Stirling, David I.; Hariri, Robert J.; Zeldis, Jerome B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2003231950

PCT Number PCT/US03/17319

PCT Pub. Number WO2003/102151

Priority 60/384,250 30.05.02 US; 60/434,833 19.12.02 US

Filing date 30 May 2003

Wipo publication date 19 December 2003

Event Publications

28 August 2003 Complete Application Filed

  Priority application(s): 60/384,250 30.05.02 US; 60/434,833 19.12.02 US

12 February 2004 Application Open to Public Inspection

  Published as AU-A-2003231950

6 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003231951-METHOD AND SYSTEM FOR INTELLIGENT STORAGE MANAGEMENT

2003231949-INKJET INKS WITH INCREASED OPTICAL DENSITY